Clinical/biochemical characteristics and related outcomes in people with new-onset diabetes and COVID-19: experience from a single centre

被引:5
|
作者
Munoz Moreno, Diego [1 ]
Anez Ramos, Roberto Jose [1 ]
Gonzalez Fernandez, Laura [1 ]
Rivas Montenegro, Alejandra Maricel [1 ]
Miguelez Gonzalez, Maria [2 ]
Brox Torrecilla, Noemi [3 ]
Gonzalez Albarran, Olga [1 ]
机构
[1] Gen Univ Gregorio Maranon Hosp, Endocrinol & Nutr Dept, Madrid 28009, Spain
[2] Fdn Jimenez Diaz, Endocrinol & Nutr Dept, Madrid, Spain
[3] Univ Hosp Ramon y Cajal, Endocrinol & Nutr Dept, Madrid, Spain
关键词
new-onset diabetes mellitus; COVID-19; SARS-CoV-2; hospital admission;
D O I
10.1002/pdi.2426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: It is known that there is a bidirectional relationship between diabetes mellitus (DM) and coronavirus disease (COVID-19). It has been described that those patients infected with SARS-CoV-2 could develop severe metabolic decompensation of pre-existing or new-onset DM, although diabetogenic effect of SARS-CoV-2 has still not been well consolidated. In fact, the coexistence of SARS-CoV-2 infection and new-onset DM is an infrequent situation. Methods: We describe the clinical and analytical characteristics of 19 patients admitted to a Spanish tertiary hospital - all 19 having COVID-19 infection and new-onset DM. Results: 12/19 patients (63.2%) were female; the mean age at diagnosis of DM was 54 (39-65) years. The most frequent ethnic group was Caucasian (n=9), followed by Latin-American (n=7); 7/19 (36.8%) previously met criteria for prediabetes due to altered basal glycaemia or HbA(1c). The mean BMI at diagnosis was 32.26kg/m(2) (27.62-35.18kg/m(2)). Eighteen of 19 patients (94.7%) showed bilateral bronchopneumonia. The mean blood glucose of the first blood was 17.5mmol/L (11.1-21.1mmol/L), and the mean HbA(1c) was 88mmol/mol (60-115mmol/mol). C-peptide was requested in eight patients and it was within normal range in 87.5% (n=7) and below the inferior threshold in one case. Autoantibodies were requested in 26.3% (five patients), being negative in 4/5 (80%) and positive in 1/5 (20%). Regarding the type of diabetes diagnosed, 18 were type 2 DM and only one case was diagnosed with type 1 DM. Seventeen had simple hyperglycaemia and two suffered a diabetic ketoacidosis. The mean HbA(1c) at 8.0 months (5.0-12.0 months) follow-up was 42mmol/mol (40-49mmol/mol). Conclusion: The majority of those described had type 2 DM that appears to have been unmasked by the COVID-19 infection, since they had high HbA(1c) and several risk factors for diabetes development, such as obesity and prediabetes. Most of them had their pancreatic reserve preserved, and this may suggest insulin resistance as the aetiology rather than direct beta-cell damage. A good evolution of diabetes after hospital discharge was observed in the patients followed up at our centre. Copyright (c) 2022 John Wiley & Sons.
引用
收藏
页码:24 / 31
页数:8
相关论文
共 50 条
  • [1] New-onset functional tics during the COVID-19 pandemic: Clinical characteristics of 105 cases from a single centre
    Cavanna, Andrea Eugenio
    Purpura, Giulia
    Riva, Anna
    Nacinovich, Renata
    Seri, Stefano
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (08) : 2411 - 2417
  • [2] New-Onset Diabetes in Covid-19
    Rubino, Francesco
    Amiel, Stephanie A.
    Zimmet, Paul
    Alberti, George
    Bornstein, Stefan
    Eckel, Robert H.
    Mingrone, Geltrude
    Boehm, Bernhard
    Cooper, Mark E.
    Chai, Zhonglin
    Del Prato, Stefano
    Ji, Linong
    Hopkins, David
    Herman, William H.
    Khunti, Kamlesh
    Mbanya, Jean-Claude
    Renard, Eric
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (08): : 789 - 790
  • [3] New-Onset Diabetes After COVID-19
    Kim, Sun H.
    Arora, Ipsa
    Hsia, Daniel S.
    Knowler, William C.
    LeBlanc, Erin
    Mylonakis, Eleftherios
    Pratley, Richard
    Pittas, Anastassios G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (11): : E1164 - E1174
  • [4] COVID-19, Hyperglycemia, and New-Onset Diabetes
    Khunti, Kamlesh
    Del Prato, Stefano
    Mathieu, Chantal
    Kahn, Steven E.
    Gabbay, Robert A.
    Buse, John B.
    DIABETES CARE, 2021, 44 (12) : 2645 - 2655
  • [5] New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis
    Dhan Bahadur Shrestha
    Pravash Budhathoki
    Sumit Raut
    Sugat Adhikari
    Prinska Ghimire
    Sabin Thapaliya
    Ali A Rabaan
    Bibodh Jung Karki
    World Journal of Virology, 2021, (05) : 275 - 287
  • [6] Prevalence, Clinical Characteristics, and Clinical Outcomes of New-onset Diabetes Mellitus among COVID-19 Patients in Developing and Developed Countries: A Review
    Junaid, Khunsa
    Dawood, Nauman
    Daood, Muhammad
    Randhawa, Fawad Ahmad
    Yousaf, Muhammad Kamran
    Ahmad, Mian Sajjad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (06): : 691 - 699
  • [7] New-onset diabetes in COVID-19: The molecular pathogenesis
    Wihandani, Desak Made
    Purwanta, Made Lady Adelaida
    Mulyani, W. Riski Widya
    Putra, I. Wayan Ardyan Sudharta
    Supadmanaba, I. Gede Putu
    BIOMEDICINE-TAIWAN, 2022, 13 (01): : 3 - 12
  • [8] Risk Factors and Outcomes of New-Onset Diabetes After Transplant: Single-Centre Experience
    Al-Ghareeb, Sumaya M.
    El-Agroudy, Amgad E.
    Al Arrayed, Sameer M.
    Al Arrayed, Ahmed
    Alhellow, Hamad A.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2012, 10 (05) : 458 - 465
  • [9] New-Onset Diabetes in Children during COVID-19: Clinical Case Report
    Aabdi, M.
    Aarab, A.
    Es-Saad, O.
    Malki, K.
    Bkiyar, H.
    Housni, B.
    CASE REPORTS IN ENDOCRINOLOGY, 2021, 2021
  • [10] Clinical and immunological characteristics of new-onset type 1 diabetes in children during the COVID-19 pandemic
    Margolis, Merav Gil
    Weizman, Sarit
    Lazar, Liora
    Yakobovich-Gavan, Michal
    Tenenbaum, Ariel
    Phillip, Moshe
    Oron, Tal
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 462 - 462